OneSource Regulatory™ introduces MyIndago™
|
||||||
The first FREE Search and Discussion Solution to Search FDA Warning and Enforcement Actions, and Office of Inspector General (OIG) Corporate Integrity Agreements and OIG Advisory Opinions
CHICAGO, IL, October 16, 2017 – OneSource Regulatory™ (OSR), the premier specialized technology-enabled professional services firm, today announced a free technology solution for individuals working in the life sciences industry, with the launch of MyIndago™.
MyIndago™ is the most effective solution for professionals working in the highly-regulated FDA environment, striving to help pharmaceutical companies maintain compliance. With MyIndago™, individuals can easily search and access FDA enforcement communications to gain transparency into what has been problematic according to the FDA. Typically, this information is posted by the FDA at the time of communication and can be accessed on their webpage, but it is not easily searchable or cataloged within a user-friendly environment. Instead of a high-priced subscription database, available only to employees in the largest organizations, MyIndago™ is a free solution available to everyone.
Co-founder and visionary of OSR, Tracy Rockney, speaks to the value of MyIndago™ as an innovative technology: “With MyIndago™, accurate information is readily available to empower decision-making to anyone, at all levels of the organization.”
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/47cf2750-9c2c-41c9-b97e-826e97ccee57
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/dcf3fa31-838e-4766-8f6c-bfb4c8f7ad38
Tracy D. Rockney-Ward OneSource Regulatory +1 (833) OSR-TEAM [email protected]


SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 



